The Coronavirus and Potential False Claims Act Cases?

$109.00

The False Claims Act is a primary tool for the United States Government to combat fraud and abuse in relation to the procurement process and the submission of claims for payment by the government. In light of COVID-19, there is increased scrutiny by the United States Department of Justice on certain conduct. There are also waivers in place, which could affect the ascertainment of whether or not the claim is “false” for purposes of the False Claims Act. This webinar integrates the False Claims Act, Coronavirus, waivers and risk mitigation.

Want a discount? Become a member by purchasing LawPracticeCLE Unlimited or Limited Time Unlimited Special!

Event Details

Webinar Date

Webinar Time

Course Type

Original Date Of Course

Course Instructor

Rachel V. Rose, JD, MBA

General Credits

1

Course Description

The False Claims Act is a primary tool for the United States Government to combat fraud and abuse in relation to the procurement process and the submission of claims for payment by the government. In light of COVID-19, there is increased scrutiny by the United States Department of Justice on certain conduct. There are also waivers in place, which could affect the ascertainment of whether or not the claim is “false” for purposes of the False Claims Act. This webinar integrates the False Claims Act, Coronavirus, waivers and risk mitigation.

Principles

  • The nuances of the FCA
  • Key aspects of the coronavirus
  • Potential areas where the FCA and Coronavirus may intersect
  • Consideration of waivers and other directives
  • Risk mitigation

Syllabus

  1. Overview of the Nuances of a False Claims Act Case
  2. Coronavirus Overview
  3. Areas of potential FCA litigation and the Coronavirus
  4. Relevant waivers under 1135 and other directives
  5. Compliance Suggestions and Take-aways

Instructor

Rachel V. Rose, JD, MBA